ADMA Biologics, Inc. (ADMA): insider & executive buying
ADMA Biologics, Inc. · Health Care · ref. ETF XLV · price $9.48
In short — 2 insiders bought ADMA Biologics, Inc. over ~6 months (4 buys, total $468k, latest May 27, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are ADMA Biologics, Inc.'s executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$9.48-45.5% over range
Aug 28, 25low $7.6 · high $20.38Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
67% recommend buying · 3 analysts
Latest insider buys on ADMA Biologics, Inc.
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| May 27, 26 | Grossman Jerrold B | Dir | 6,400 | $51k |
| May 12, 26 | Grossman Jerrold B | Dir | 12,500 | $100k |
| May 11, 26 | Grossman Jerrold B | Dir | 12,500 | $100k |
| Mar 5, 26 | Elms Steve | Dir | 14,000 | $217k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have ADMA Biologics, Inc.'s executives bought shares recently?
2 ADMA Biologics, Inc. insider(s) bought $468k over ~6 months (latest May 27, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for ADMA?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about ADMA Biologics, Inc.? The JPI assistant answers using our backtest data.
Keep exploring ADMA Biologics, Inc.